Method for preparing acrolein from glycerol or glycerine
    8.
    发明授权
    Method for preparing acrolein from glycerol or glycerine 有权
    从甘油或甘油制备丙烯醛的方法

    公开(公告)号:US09447009B2

    公开(公告)日:2016-09-20

    申请号:US14010724

    申请日:2013-08-27

    Abstract: A method of preparing acrolein from glycerol or glycerine is disclosed. The method includes dehydrating glycerol or glycerine in the presence of a catalyst consisting of at least (a) a mixed oxide of zirconium and at least one metal, said metal being selected from niobium, tantalum and vanadium, or (b) a zirconium oxide and at least one metal oxide, the metal being selected from niobium, tantalum and vanadium, or (c) a silicon oxide and a mixed oxide of zirconium and at least one metal, the metal being selected from tungsten, cerium, manganese, niobium, tantalum, titanium, vanadium and silicon, or (d) a titanium oxide and a mixed oxide of zirconium and at least one metal, said metal being selected from tungsten, cerium, manganese, niobium, tantalum, titanium, vanadium and silicon.

    Abstract translation: 公开了从甘油或甘油制备丙烯醛的方法。 所述方法包括在由至少(a)锆和至少一种金属的混合氧化物组成的催化剂存在下脱水甘油或甘油,所述金属选自铌,钽和钒,或(b)氧化锆和 至少一种金属氧化物,所述金属选自铌,钽和钒,或(c)氧化硅和锆与至少一种金属的混合氧化物,所述金属选自钨,铈,锰,铌,钽 ,钛,钒和硅,或(d)二氧化钛和锆与至少一种金属的混合氧化物,所述金属选自钨,铈,锰,铌,钽,钛,钒和硅。

    Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels
    9.
    发明授权
    Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels 有权
    降低甘油三酯,总胆固醇和低密度脂蛋白血药浓度的方法

    公开(公告)号:US09358217B2

    公开(公告)日:2016-06-07

    申请号:US14540766

    申请日:2014-11-13

    Inventor: Kazuko Matsuda

    CPC classification number: A61K31/192 C07C323/22

    Abstract: A compound of Formula (I): or a metabolite thereof, or an ester of the compound of Formula (I) or the metabolite thereof, or a pharmaceutically acceptable salt of each thereof, wherein m, n, X1 and X2 are as defined herein, is useful for reducing blood levels of one or more of triglycerides (TG), total cholesterol (TC) and low density lipoprotein (LDL) in human subjects.

    Abstract translation: 式(I)的化合物或其代谢物,或式(I)化合物或其代谢物的酯或其各自的药学上可接受的盐,其中m,n,X1和X2如本文所定义 可用于降低人类受试者中甘油三酯(TG),总胆固醇(TC)和低密度脂蛋白(LDL)中的一种或多种的血液水平。

Patent Agency Ranking